Inhaled nitric oxide therapy via nasopharyngeal tube in an infant with end-stage pulmonary hypertension.
The delivery of nitric oxide (NO) via a nasopharyngeal tube is an alternative to endotracheal intubation. A male infant with end-stage pulmonary hypertension (PH) due to a severe hypoplastic lung developed a PH crisis on day 145 and received NO inhalation via a nasopharyngeal tube. Clinical improvement was maintained for 7 days with 18-22 ppm NO inhalation. The patient remained in close physical contact with his parents without the use of sedation. Blood methemoglobin levels remained below 1%. The environmental NO levels were less than 0.06 ppm and NO2 less than 0.3 ppm throughout the treatment, well within the safety margin. On day 152, the patient succumbed to hypoxemia and heart failure. The use of a nasopharyngeal NO delivery system without sedation, as an alternative to endotracheal intubation with sedation, was a practical method in treating a patient with PH while maintaining a certain quality of life for the patient and the family.
Kakuya
F
F
Department of Pediatrics, Asahikawa Medical College, Japan.
Takase
M
M
Ishii
N
N
Kajino
M
M
Hayashi
T
T
Miyamoto
K
K
Muraki
S
S
Iwamoto
J
J
Okuno
A
A
D000280:Administration, Inhalation; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D007231:Infant, Newborn; D007440:Intubation; D008297:Male; D009305:Nasopharynx; D009569:Nitric Oxide / Q000008:administration & dosage*
D009569:Nitric Oxide